Literature DB >> 18725408

Characterization of the Ca2+ -regulated ezrin-S100P interaction and its role in tumor cell migration.

Judith Austermann1, Ali Reza Nazmi, Carsten Müller-Tidow, Volker Gerke.   

Abstract

Ezrin is a multidomain protein providing regulated membrane-cytoskeleton contacts that play a role in cell differentiation, adhesion, and migration. Within the cytosol of resting cells ezrin resides in an autoinhibited conformation in which the N- and C-terminal ezrin/radixin/moesin (ERM) association domains (ERMADs) interact with one another. Activation of the ezrin membrane-cytoskeleton linker function requires an opening of this interdomain association that can result from phosphatidylinositol 4,5-bisphosphate binding to the N-ERMAD and threonine 567 phosphorylation in the C-ERMAD. We have shown that ezrin can also be activated by Ca(2+)-dependent binding of the EF-hand protein S100P. We now provide a quantitative analysis of this interaction and map the respective binding sites to the F2 lobe in the ezrin N-ERMAD and a stretch of hydrophobic residues in the C-terminal extension of S100P. Phospholipid binding assays reveal that S100P and phosphatidylinositol 4,5-bisphosphate compete to some extent for at least partially overlapping binding sites in N-ERMAD. Using interaction-competent as well as interaction-incompetent S100P derivatives and permanently active ezrin mutants, we also show that the protein interaction and a resulting activation of ezrin promote the transendothelial migration of tumor cells. Thus, a prometastatic role of ezrin and S100P that had been proposed based on their overexpression in highly metastatic cancers is probably due to a direct interaction between the two proteins and the S100P-mediated activation of ezrin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18725408      PMCID: PMC2662020          DOI: 10.1074/jbc.M806145200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Crystallization and preliminary crystallographic analysis of the ezrin FERM domain.

Authors:  William J Smith; Richard A Cerione
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-07-20

2.  The crystal structure at 2A resolution of the Ca2+ -binding protein S100P.

Authors:  Hongmei Zhang; Guozheng Wang; Yi Ding; Zhilong Wang; Roger Barraclough; Philip S Rudland; David G Fernig; Zihe Rao
Journal:  J Mol Biol       Date:  2003-01-24       Impact factor: 5.469

3.  Ca2+-dependent binding and activation of dormant ezrin by dimeric S100P.

Authors:  Max Koltzscher; Claudia Neumann; Simone König; Volker Gerke
Journal:  Mol Biol Cell       Date:  2003-06       Impact factor: 4.138

4.  Spatiotemporal regulation of moesin phosphorylation and rear release by Rho and serine/threonine phosphatase during neutrophil migration.

Authors:  Naoko Yoshinaga-Ohara; Atsushi Takahashi; Takashi Uchiyama; Masataka Sasada
Journal:  Exp Cell Res       Date:  2002-08-01       Impact factor: 3.905

Review 5.  ERM proteins and merlin: integrators at the cell cortex.

Authors:  Anthony Bretscher; Kevin Edwards; Richard G Fehon
Journal:  Nat Rev Mol Cell Biol       Date:  2002-08       Impact factor: 94.444

6.  Endothelial intracellular Ca2+ release following monocyte adhesion is required for the transendothelial migration of monocytes.

Authors:  K Kielbassa-Schnepp; A Strey; A Janning; L Missiaen; B Nilius; V Gerke
Journal:  Cell Calcium       Date:  2001-07       Impact factor: 6.817

7.  Structure of the active N-terminal domain of Ezrin. Conformational and mobility changes identify keystone interactions.

Authors:  William James Smith; Nicolas Nassar; Anthony Bretscher; Richard A Cerione; P Andrew Karplus
Journal:  J Biol Chem       Date:  2002-11-11       Impact factor: 5.157

8.  Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility.

Authors:  T Ng; M Parsons; W E Hughes; J Monypenny; D Zicha; A Gautreau; M Arpin; S Gschmeissner; P J Verveer; P I Bastiaens; P J Parker
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

9.  Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.

Authors:  W Wick; C Grimmel; C Wild-Bode; M Platten; M Arpin; M Weller
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

10.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis.

Authors:  Erik Sahai; Christopher J Marshall
Journal:  Nat Cell Biol       Date:  2003-08       Impact factor: 28.824

View more
  31 in total

1.  S100P is a novel interaction partner and regulator of IQGAP1.

Authors:  Annika Heil; Ali Reza Nazmi; Max Koltzscher; Michaela Poeter; Judith Austermann; Nicole Assard; Jacques Baudier; Kozo Kaibuchi; Volker Gerke
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

Review 2.  S100P: a novel therapeutic target for cancer.

Authors:  Thiruvengadam Arumugam; Craig D Logsdon
Journal:  Amino Acids       Date:  2010-05-28       Impact factor: 3.520

3.  LncRNA NORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P.

Authors:  Boon-Shing Tan; Min-Chi Yang; Shaifali Singh; Yu-Chi Chou; Hsin-Yi Chen; Ming-Yang Wang; Yi-Ching Wang; Ruey-Hwa Chen
Journal:  Oncogene       Date:  2019-04-09       Impact factor: 9.867

4.  Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness.

Authors:  Syreeta L Tilghman; Ian Townley; Qiu Zhong; Patrick P Carriere; Jin Zou; Shawn D Llopis; Lynez C Preyan; Christopher C Williams; Elena Skripnikova; Melyssa R Bratton; Qiang Zhang; Guangdi Wang
Journal:  Mol Cell Proteomics       Date:  2013-05-23       Impact factor: 5.911

Review 5.  Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.

Authors:  Hongfei Jiang; Hang Hu; Xiaomei Tong; Qiuhong Jiang; Haiyan Zhu; Songying Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-24       Impact factor: 4.553

Review 6.  The ezrin-radixin-moesin family of proteins in the regulation of B-cell immune response.

Authors:  Debasis Pore; Neetu Gupta
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

7.  Interactome analysis reveals ezrin can adopt multiple conformational states.

Authors:  Raghuvir Viswanatha; Jessica Wayt; Patrice Y Ohouo; Marcus B Smolka; Anthony Bretscher
Journal:  J Biol Chem       Date:  2013-10-22       Impact factor: 5.157

8.  S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma.

Authors:  Lu-Nan Qi; Liang Ma; Fei-Xiang Wu; Yuan-Yuan Chen; Wan-Ting Xing; Zhi-Jun Jiang; Jian-Hong Zhong; Zu-Shun Chen; Wen-Feng Gong; Jia-Zhou Ye; Hong-Hao Li; Jin-Jie Shang; Bang-De Xiang; Le-Qun Li
Journal:  Hepatol Int       Date:  2021-01-25       Impact factor: 6.047

Review 9.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

Review 10.  S100 protein family in human cancer.

Authors:  Hongyan Chen; Chengshan Xu; Qing'e Jin; Zhihua Liu
Journal:  Am J Cancer Res       Date:  2014-03-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.